Help shape the future of Fragile X syndrome treatment by sharing your thoughts on gene therapy. Your input is vital as we explore potential new treatments that target the genetic cause of FXS. Participate in the Patrick Wild Centre’s survey today and make your voice heard in this important research.
Read moreUniversity of Edinburgh, Scotland
Somatosensory Processing as a Therapeutic Target for Fragile X Syndrome
![Somatosensory Processing as a Therapeutic Target for Fragile X Syndrome](https://www.fraxa.org/wp-content/uploads/2023/04/Leena-E.-Williams-Andrew-Stanfield-Damien-Wright--720x300.jpg)
Awarded a FRAXA Research grant, Dr. Andrew Stanfield, Dr. Leena E. Williams, and Dr. Damien Wright are set to explore somatosensory processing (sense of touch) in Fragile X syndrome at the University of Edinburgh. Their aim? A noninvasive touch test that could set the stage for future clinical trials in FXS.
Read moreEnhancement of NMDA Receptor Signaling for the Treatment of Fragile X Syndrome
![Enhancement of NMDA Receptor Signaling for the Treatment of Fragile X Syndrome Emily Osterweil](https://www.fraxa.org/wp-content/uploads/2016/08/osterweil-720x300.jpg)
FRAXA Research Foundation funded a 2016-2017 Fellowship for Dr. Stephanie Barnes in the University of Edinburgh lab of Dr. Emily Osterweil. With this $90,000 award, the team is investigating NMDA signaling in fragile X syndrome mice.
Read moreDevelopment of the Fragile X Brain: Cellular Processes Regulated by FMRP During Development
![Development of the Fragile X Brain: Cellular Processes Regulated by FMRP During Development Peter Kind, PhD, of University of Edinburgh, FRAXA research grant](https://www.fraxa.org/wp-content/uploads/2008/07/kind-peter.jpg)
With a $120,000 grant from FRAXA Research Foundation over 2 years, Dr. Peter Kind and his team at the University of Edinburgh will study the way FMRP affects and is affected by cortical development.
Read more